The body has enzymes that convert most GSSG back into the active GSH form, continuously replenishing the supply
DPP-4 Inhibitors Mechanism of action Competitive inhibition of dipeptidyl-peptidase 4 slows degradation of endogenous incretins (GLP-1, GIP) Glucose-dependent insulin secretion Post-prandial glucagon release No direct effect on weight or insulin sensitivity Glycaemic efficacy Advantages Weight-neutral useful when metformin + SU cause weight concern Low hypoglycaemia risk (incretin-dependent action) Oral, generally once-daily
While Tuell et al
Moving into Month 2, I switched to Melanotan 1, injecting twice weekly to maintain my tan
Rezvan N, Moini A, Janani L, Mohammad K, Saedisomeolia A, Nourbakhsh M, et al
Explore our weight loss program, which includes GLP-1 medications, to learn how these treatments can work together for better results